Marginal cost of operating a positron emission tomography center in a regulatory environment.
about
A systematic review of PET and PET/CT in oncology: a way to personalize cancer treatment in a cost-effective manner?Unexpected Benefit of the Positron Emission Tomography/Computed Tomography Using 18F-Fluorodeoxyglucose: Report of a Case.Assessing short-term effects and costs at an early stage of innovation: the use of positron emission tomography on radiotherapy treatment decision making.[Cost analysis of18F-FDG PET-CT from the perspective of the Brazilian Unified National Health System as healthcare provider: a study in a public healthcare center in Rio de Janeiro, Brazil].On the significance of defective block detectors in clinical (18)F-FDG PET/CT imaging.Is there still a role for SPECT–CT in oncology in the PET–CT era?
P2860
Marginal cost of operating a positron emission tomography center in a regulatory environment.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Marginal cost of operating a p ...... r in a regulatory environment.
@en
Marginal cost of operating a p ...... r in a regulatory environment.
@nl
type
label
Marginal cost of operating a p ...... r in a regulatory environment.
@en
Marginal cost of operating a p ...... r in a regulatory environment.
@nl
prefLabel
Marginal cost of operating a p ...... r in a regulatory environment.
@en
Marginal cost of operating a p ...... r in a regulatory environment.
@nl
P2093
P2860
P1476
Marginal cost of operating a p ...... r in a regulatory environment.
@en
P2093
Alexander J B McEwan
Anderson Chuck
Chester Chmielowiec
Donald St Hilaire
J Wayne Logus
Philip Jacobs
P2860
P304
P356
10.1017/S0266462305050610
P577
2005-01-01T00:00:00Z